Polypeptides comprising fas activation and nkg2d-ligand domains

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/705 (2006.01) A61K 31/713 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01) C12N 15/62 (2006.01)

Patent

CA 2670790

The present invention is drawn to fusion proteins comprising (a) a ligand for an NK receptor and (b) an intracytoplasmic death domain, and to nucleic acids encoding such fusion proteins. The invention also includes methods of making and using such proteins and nucleic acids, including their use in preventing or treating cancer.

L'invention se rapporte à des protéines de fusion comprenant (a) un ligand de récepteur NK et (b) un domaine d'activation Fas, et à des acides nucléiques codant lesdites protéines de fusion. L'invention concerne également des procédés de fabrication et d'utilisation des protéines et acides nucléiques précités, y compris dans la prévention ou le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Polypeptides comprising fas activation and nkg2d-ligand domains does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptides comprising fas activation and nkg2d-ligand domains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides comprising fas activation and nkg2d-ligand domains will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1745494

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.